[Digoxin in treatment of chronic insufficiency and changes of functional state of the pancreas]

Likars'Ka Sprava
|January 7, 2006
PubMed

Insights

This study highlights managing chronic heart insufficiency with concurrent pancreatic issues. Digoxin effectively improved heart function and pancreatic ultrasound results in patients with systolic heart insufficiency.

Area of Science:

  • Cardiology
  • Gastroenterology
  • Pharmacology

Background:

  • Combined cardiovascular and gastroenterological system damage presents complex clinical challenges.
  • Chronic heart insufficiency (CHI) management requires consideration of co-existing conditions.
  • Systolic and diastolic blood pressure components necessitate differential patient management.

Purpose of the Study:

  • To investigate the impact of managing chronic heart insufficiency on the gastroenterological system, specifically the pancreas.
  • To evaluate treatment strategies for patients with combined cardiovascular and pancreatic conditions.
  • To determine the efficacy of digoxin in patients with systolic heart insufficiency and pancreatic congestion.

Main Methods:

  • Observational study of patients with chronic heart insufficiency.
  • Differential management based on systolic or diastolic blood pressure prevalence.
  • Assessment of pancreatic congestion and ultrasound characteristics.
  • Evaluation of treatment effects on left ventricular ejection factor.

Main Results:

  • Systolic heart insufficiency (left ventricular ejection factor < 40%) was prevalent.
  • Digoxin treatment demonstrated efficacy in patients with CHI and pancreatic congestion.
  • Significant enhancement of left ventricular ejection factor was observed.
  • Improvement in pancreatic ultrasound characteristics was noted post-treatment.

Conclusions:

  • Digoxin is an effective treatment for chronic heart insufficiency with pancreatic congestion, particularly in systolic CHI.
  • Differential management strategies are crucial for patients with combined cardiovascular and pancreatic diseases.
  • Treatment of cardiac dysfunction can positively influence pancreatic health.

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...